AmSECT (American Society of ExtraCorporeal Technology) is a health care startup established in 1964 in the United States. The organization's slogan, "Our mission is to foster improved patient care & safety by providing education and professional needs to perfusionists," encapsulates its commitment to driving advancements in patient care. AmSECT's core focus lies in advancing patient care and safety by catering to the educational and professional requirements of the extracorporeal circulation technology community. Since its inception, AmSECT has steadily expanded its membership base, which currently exceeds 2,000 members worldwide. The startup's objectives encompass various initiatives such as advocating for licensure support through government relations, setting professional standards for perfusion, extending the scope of perfusion practice, and nurturing the next generation of perfusionists through educational programs. Additionally, AmSECT is dedicated to the dissemination of scientific knowledge through its indexed Journal of ExtraCorporeal Technology and the publication of a bi-monthly newsletter, AmSECT Today. The startup's evolution has been closely intertwined with advancements in cardiac disease treatment and the heightened demand for open-heart surgery. In adapting to the changing landscape, Perfusionists associated with AmSECT have embraced new opportunities, including expanded practices in perioperative blood management, ventricular assistance, wound healing, and varied applications of extracorporeal circulation. While specific details regarding the startup's recent investments and investors are currently unavailable, AmSECT's sustained growth and global outreach indicate its potential for further impact and expansion within the health care industry.
There is no investment information
No recent news or press coverage available for AmSECT (American Society of ExtraCorporeal Technology).